Trademark: 86266109
Word
SAFETYMAP
Status
Dead
Status Code
710
Status Date
Friday, April 8, 2022
Serial Number
86266109
Registration Number
4820587
Registration Date
Tuesday, September 29, 2015
Mark Type
4000
Filing Date
Tuesday, April 29, 2014
Published for Opposition
Tuesday, July 14, 2015
Cancellation Date
Friday, April 8, 2022

Trademark Owner History
Molecular Health GmbH - Original Registrant

Classifications
9 Medical and clinical laboratory apparatus and instruments for next generation sequencing of genomic DNA for the purpose of cancer diagnostic molecular testing, in particular, cancer genomic testing and testing of genomic changes, and related automated decision support tools for diagnostic and therapeutic application, namely, computer application software and hardware for use with the laboratory apparatus and instruments
44 Providing online databases featuring medical information and diagnostic, prophylactic and therapeutic properties of pharmaceuticals, and genomic information as it relates to medical diagnosis and treatment; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options, in particular in the field of clinical diagnostics and therapy, in particular in the field of cancer diagnostics and cancer therapy; medical consulting services with respect to the treatment and diagnosis of individuals with cancer in the fields of clinical pharmacology and the analysis of dose-effect relationships for treatment purposes; medical consulting services in the fields of patient treatments and treatment protocols for cancer
42 Data collection for scientific research, analytical and clinical purposes, in particular the collection and systematic sorting of patient's specific molecular, genomic and/or clinical data, in particular relating to genomic changes, in particular relating to cancer genomic changes; providing medical research information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; scientific clinical studies in the field of medicine; data collection for scientific research and analytical purposes, in particular the collection of mathematical and statistical data, clinical data, patient's genomic data and data of clinical studies relating to patient's clinical responses to drug treatments and treatment regimes; compiling data for research and analytical purposes in the field of medical science and diagnostics, in particular compiling patient specific molecular and genomic data, in particular cancer genomic data; scientific, technical and research services, namely, scientific, technical and medical research for medical purposes in the field of medical diagnostic and optimization of treatment regimes; providing medical and scientific research information and scientific research consulting in the fields of pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and interpretation of analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of data obtained from cancer patients, specifically patient's genomic changes that contribute to a patient's unique cancer disease; providing an online database featuring medical, pharmaceutical, biological and genomic scientific research information for medical and diagnostic purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic scientific research information for scientific research, analytical and clinical purposes; providing an online searchable database featuring scientific research in the fields of cancer medicine, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis; design and development of computer software in the fields of biology, medicine, and bioinformatics; design and development of computer software for integration of patient's specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment, in particular in the field of cancer diagnosis and therapy; design and development of databases featuring biomarker data; providing an online searchable database featuring scientific research information in the fields of analysis and optimization of protocols used in cancer treatment, for medical, diagnostic and clinical use; Software as a Service (SAAS) services featuring software for providing information for patient's treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, in particular designing and conducting scientific research drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others; providing pharmaceutical scientific and medical research information, in particular research information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; consulting services in the fields of pharmaceuticals and genetics, in particular conducting scientific research in drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; electronic storage of medical data and information for physicians and healthcare professionals; providing an on-line, non-downloadable computer platform for purposes of storing and providing information about patient's individual cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice
SAFETY MAP

Trademark Events
Apr 8, 2022
Cancelled Sec. 8 (6-Yr)
Sep 29, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Sep 29, 2015
Registered-Principal Register
Jul 14, 2015
Official Gazette Publication Confirmation E-Mailed
Jul 14, 2015
Published For Opposition
Jun 24, 2015
Notification Of Notice Of Publication E-Mailed
May 26, 2015
Withdrawn From Pub - Og Review Query
May 11, 2015
Law Office Publication Review Completed
May 7, 2015
Approved For Pub - Principal Register
Apr 15, 2015
Teas/Email Correspondence Entered
Apr 15, 2015
Correspondence Received In Law Office
Apr 8, 2015
Teas Response To Suspension Inquiry Received
Mar 16, 2015
Notification Of Letter Of Suspension E-Mailed
Mar 16, 2015
Letter Of Suspension E-Mailed
Mar 16, 2015
Suspension Letter Written
Feb 23, 2015
Teas/Email Correspondence Entered
Feb 23, 2015
Correspondence Received In Law Office
Feb 16, 2015
Assigned To Lie
Feb 12, 2015
Teas Response To Office Action Received
Feb 9, 2015
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 9, 2015
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 13, 2014
Notification Of Non-Final Action E-Mailed
Aug 13, 2014
Non-Final Action E-Mailed
Aug 13, 2014
Non-Final Action Written
Aug 11, 2014
Assigned To Examiner
May 14, 2014
Notice Of Pseudo Mark E-Mailed
May 13, 2014
New Application Office Supplied Data Entered In Tram
May 2, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24